[go: up one dir, main page]

WO2003106635A9 - Functional sites - Google Patents

Functional sites Download PDF

Info

Publication number
WO2003106635A9
WO2003106635A9 PCT/US2003/018714 US0318714W WO03106635A9 WO 2003106635 A9 WO2003106635 A9 WO 2003106635A9 US 0318714 W US0318714 W US 0318714W WO 03106635 A9 WO03106635 A9 WO 03106635A9
Authority
WO
WIPO (PCT)
Prior art keywords
functional sites
sites
functional
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2003/018714
Other languages
French (fr)
Other versions
WO2003106635A2 (en
Inventor
John A. Stamatoyannopoulos
Michael Mcarthur
Peter J. Sabo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Regulome Corp
Original Assignee
Regulome Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Regulome Corp filed Critical Regulome Corp
Priority to AU2003245488A priority Critical patent/AU2003245488A1/en
Publication of WO2003106635A2 publication Critical patent/WO2003106635A2/en
Anticipated expiration legal-status Critical
Publication of WO2003106635A9 publication Critical patent/WO2003106635A9/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
PCT/US2003/018714 2002-06-13 2003-06-13 Functional sites Ceased WO2003106635A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2003245488A AU2003245488A1 (en) 2002-06-13 2003-06-13 Functional sites

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US38788702P 2002-06-13 2002-06-13
US38791002P 2002-06-13 2002-06-13
US60/387,910 2002-06-13
US60/387,887 2002-06-13

Publications (2)

Publication Number Publication Date
WO2003106635A2 WO2003106635A2 (en) 2003-12-24
WO2003106635A9 true WO2003106635A9 (en) 2010-01-21

Family

ID=29739965

Family Applications (2)

Application Number Title Priority Date Filing Date
PCT/US2003/018714 Ceased WO2003106635A2 (en) 2002-06-13 2003-06-13 Functional sites
PCT/IB2003/004491 Ceased WO2004005458A2 (en) 2002-06-13 2003-06-13 Functional sites

Family Applications After (1)

Application Number Title Priority Date Filing Date
PCT/IB2003/004491 Ceased WO2004005458A2 (en) 2002-06-13 2003-06-13 Functional sites

Country Status (2)

Country Link
AU (2) AU2003245488A1 (en)
WO (2) WO2003106635A2 (en)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040121311A1 (en) 2002-12-06 2004-06-24 Ecker David J. Methods for rapid detection and identification of bioagents in livestock
US7718354B2 (en) 2001-03-02 2010-05-18 Ibis Biosciences, Inc. Methods for rapid identification of pathogens in humans and animals
US7666588B2 (en) 2001-03-02 2010-02-23 Ibis Biosciences, Inc. Methods for rapid forensic analysis of mitochondrial DNA and characterization of mitochondrial DNA heteroplasmy
US7226739B2 (en) 2001-03-02 2007-06-05 Isis Pharmaceuticals, Inc Methods for rapid detection and identification of bioagents in epidemiological and forensic investigations
US20030027135A1 (en) 2001-03-02 2003-02-06 Ecker David J. Method for rapid detection and identification of bioagents
US7271240B2 (en) 2001-03-14 2007-09-18 Agensys, Inc. 125P5C8: a tissue specific protein highly expressed in various cancers
US7217510B2 (en) 2001-06-26 2007-05-15 Isis Pharmaceuticals, Inc. Methods for providing bacterial bioagent characterizing information
US8073627B2 (en) 2001-06-26 2011-12-06 Ibis Biosciences, Inc. System for indentification of pathogens
US20040019915A1 (en) 2002-04-01 2004-01-29 Challita-Eid Pia M. Nucleic acid and corresponding protein entitled 213P1F11 useful in treatment and detection of cancer
CA2508726A1 (en) 2002-12-06 2004-07-22 Isis Pharmaceuticals, Inc. Methods for rapid identification of pathogens in humans and animals
US8046171B2 (en) 2003-04-18 2011-10-25 Ibis Biosciences, Inc. Methods and apparatus for genetic evaluation
US8057993B2 (en) 2003-04-26 2011-11-15 Ibis Biosciences, Inc. Methods for identification of coronaviruses
US7964343B2 (en) 2003-05-13 2011-06-21 Ibis Biosciences, Inc. Method for rapid purification of nucleic acids for subsequent analysis by mass spectrometry by solution capture
US8158354B2 (en) 2003-05-13 2012-04-17 Ibis Biosciences, Inc. Methods for rapid purification of nucleic acids for subsequent analysis by mass spectrometry by solution capture
US20120122096A1 (en) 2003-09-11 2012-05-17 Rangarajan Sampath Compositions for use in identification of bacteria
US8097416B2 (en) 2003-09-11 2012-01-17 Ibis Biosciences, Inc. Methods for identification of sepsis-causing bacteria
US7666592B2 (en) 2004-02-18 2010-02-23 Ibis Biosciences, Inc. Methods for concurrent identification and quantification of an unknown bioagent
US8119336B2 (en) 2004-03-03 2012-02-21 Ibis Biosciences, Inc. Compositions for use in identification of alphaviruses
US7365058B2 (en) 2004-04-13 2008-04-29 The Rockefeller University MicroRNA and methods for inhibiting same
WO2005117270A2 (en) 2004-05-24 2005-12-08 Isis Pharmaceuticals, Inc. Mass spectrometry with selective ion filtration by digital thresholding
US20050266411A1 (en) 2004-05-25 2005-12-01 Hofstadler Steven A Methods for rapid forensic analysis of mitochondrial DNA
US7811753B2 (en) 2004-07-14 2010-10-12 Ibis Biosciences, Inc. Methods for repairing degraded DNA
WO2006135400A2 (en) 2004-08-24 2006-12-21 Isis Pharmaceuticals, Inc. Methods for rapid identification of recombinant organisms
JP2008526194A (en) * 2004-12-30 2008-07-24 ヴィート ミケーレ ファツィオ Anti-tumor immunogenic peptide and vaccine thereof
US8084207B2 (en) 2005-03-03 2011-12-27 Ibis Bioscience, Inc. Compositions for use in identification of papillomavirus
US8182992B2 (en) 2005-03-03 2012-05-22 Ibis Biosciences, Inc. Compositions for use in identification of adventitious viruses
CA2616281C (en) 2005-07-21 2014-04-22 Isis Pharmaceuticals, Inc. Methods for rapid identification and quantitation of mitochondrial dna variants
EP2006382B1 (en) * 2006-04-11 2016-08-03 Eisai R&D Management Co., Ltd. Dopamine-producing neuron progenitor cell marker 187a5
CA2663029C (en) 2006-09-14 2016-07-19 Ibis Biosciences, Inc. Targeted whole genome amplification method for identification of pathogens
JP5680304B2 (en) 2007-02-23 2015-03-04 アイビス バイオサイエンシズ インコーポレイティッド Rapid forensic DNA analysis
EP2152873A2 (en) * 2007-03-16 2010-02-17 Biorigen S.r.l Gene expression regulation technology and noncoding rnas for diagnosis and therapy
US7695916B2 (en) * 2007-03-22 2010-04-13 Celera Corporation Genetic polymorphisms associated with coronary events and drug response, methods of detection and uses thereof
US9598724B2 (en) 2007-06-01 2017-03-21 Ibis Biosciences, Inc. Methods and compositions for multiple displacement amplification of nucleic acids
JP5301652B2 (en) 2008-07-25 2013-09-25 インフォコム株式会社 New oncogene NRF2
WO2010033625A1 (en) 2008-09-16 2010-03-25 Ibis Biosciences, Inc. Microplate handling systems and related computer program products and methods
US8550694B2 (en) 2008-09-16 2013-10-08 Ibis Biosciences, Inc. Mixing cartridges, mixing stations, and related kits, systems, and methods
WO2010033627A2 (en) 2008-09-16 2010-03-25 Ibis Biosciences, Inc. Sample processing units, systems, and related methods
CN102388139A (en) * 2008-11-04 2012-03-21 艾德拉药物股份有限公司 Modulation of toll-like receptor 5 expression by antisense oligonucleotides
US8158936B2 (en) 2009-02-12 2012-04-17 Ibis Biosciences, Inc. Ionization probe assemblies
US8950604B2 (en) 2009-07-17 2015-02-10 Ibis Biosciences, Inc. Lift and mount apparatus
WO2011008972A1 (en) 2009-07-17 2011-01-20 Ibis Biosciences, Inc. Systems for bioagent identification
US9890408B2 (en) 2009-10-15 2018-02-13 Ibis Biosciences, Inc. Multiple displacement amplification
TWI524901B (en) 2010-09-29 2016-03-11 艾澤西公司 Antibody drug conjugate (ADC) that binds to the 191P4D12 protein
EP2737057B1 (en) 2011-07-27 2018-10-24 Kyoto University Novel markers for dopaminergic neuron progenitor cells
WO2015024017A2 (en) * 2013-08-16 2015-02-19 President And Fellows Of Harvard College Rna polymerase, methods of purification and methods of use
WO2016037138A1 (en) * 2014-09-04 2016-03-10 Memorial Sloan-Kettering Cancer Center Global gene therapy for treating hemoglobinopathies
US10450572B2 (en) * 2016-08-12 2019-10-22 Regents Of The University Of Minnesota Androgen receptor variant inhibitors and methods of using
AU2019392090A1 (en) 2018-12-03 2021-06-17 Agensys, Inc. Pharmaceutical compositions comprising anti-191P4D12 antibody drug conjugates and methods of use thereof
CN114864002B (en) * 2022-04-28 2023-03-10 广西科学院 A method for identifying transcription factor binding sites based on deep learning
WO2025151744A1 (en) * 2024-01-10 2025-07-17 University Of Tennessee Research Foundation Improved globin and other lentiviral vectors for gene therapy
CN120927888A (en) * 2024-03-15 2025-11-11 深圳市药品检验研究院（深圳市医疗器械检测中心） Rhodiola rosea digital thin-layer chromatography detection analysis model and establishment method and application thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1330543A4 (en) * 2000-10-02 2006-03-29 Bayer Ag NUCLEIC ACID SEQUENCES DIFFERENTIALLY EXPRESSED IN CANCER TISSUE

Also Published As

Publication number Publication date
AU2003245488A1 (en) 2003-12-31
AU2003245488A8 (en) 2010-02-11
WO2003106635A2 (en) 2003-12-24
WO2004005458A2 (en) 2004-01-15
WO2004005458A3 (en) 2007-12-21
AU2003276494A1 (en) 2004-01-23
AU2003276494A8 (en) 2004-01-23

Similar Documents

Publication Publication Date Title
WO2003106635A9 (en) Functional sites
AU2002335152A1 (en) Robot-phone
AU2002367810A1 (en) Bis-transition-metal-chelate-probes
AU2003298556A1 (en) Functional sites
AU2002368348A1 (en) Electrosomatogram
AU2002318053A1 (en) Suplier
AU2002341221A1 (en) Honey-brandy
AU2002348964A1 (en) Snowbike
AU2002344387A1 (en) Multifunction-pillow
AU2002100468A4 (en) Flexi-edger
AU2002100747A4 (en) Powersell
AU2002100510A4 (en) Bottlenecker
AU2002100541A4 (en) Backmate
AU2002100602A4 (en) Bonsystem
AU2002100655A4 (en) Armamulch
AU2002100739A4 (en) Neuramax
AU2002100508A4 (en) Photocard
AU2002100957A4 (en) Sluggit
AU2002100498A4 (en) Linline
AU2002100482A4 (en) Tail-gate-ezy
AU2002100160A4 (en) Oxidirator
AU2002100031A4 (en) earliPay
AU2002100026A4 (en) Disc400
AU2002950535A0 (en) Austraila Extension
AU2002951106A0 (en) Cashramspam

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase in:

Ref country code: DE

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase in:

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP